Activatable INTERLEUKIN-2 Polypeptides
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2019/032321, filed May 14, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,696,724 | Activatable INTERLEUKIN-2 Polypeptides In force · High confidence UsedRemaining | EMD Serono, Inc. | In force | High confidence | ||
| US 11,352,403 | Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof In force · High confidence | EMD Serono, Inc. | In force | High confidence | ||
| US 11,535,658 | Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof In force · Medium confidence | EMD Serono, Inc. | In force | Medium confidence | ||
| US 12,534,505 | Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof In force · Medium confidence | EMD Serono, Inc. | In force | Medium confidence | ||
| US 11,981,716 | Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof In force · Medium confidence | EMD Serono, Inc. | In force | Medium confidence | ||
| Application 19/423,455 | Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof Pending Not granted | EMD Serono, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Werewolf Therapeutics, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.